Is distortion of the bioprosthesis ring a risk factor for early calcification ?
Background As the population ages, bioprosthesis are increasingly being used in cardiac valve replacement. Pericardial bioprosthesis combine an excellent hemodynamic performance with low thrombogenicity, but valve failure associated with calcification ...
de Alegria Anxo +4 more
doaj +2 more sources
Real-world early- to midterm outcomes of aortic valve replacement using novel tissue technology bioprosthesis at a high-volume centerCentral MessagePerspective [PDF]
Objective: The INSPIRIS-RESILIA aortic valve (Edwards Lifesciences) uses a novel tissue-fixation technology to enhance the bioprosthesis's longevity. We sought to report midterm INSPIRIS-RESILIA aortic bioprosthesis performance in a large contemporary ...
Emily Vianna, MD +9 more
doaj +2 more sources
BACKGROUND: Transcatheter aortic valve implantation (TAVI) has become a standard therapeutic option for patients with severe aortic stenosis (AS) at high cardiac surgical risk.
Dariusz Jagielak +7 more
doaj +4 more sources
Experimental Study and Early Clinical Application Of a Sutureless Aortic Bioprosthesis
INTRODUCTION: The conventional aortic valve replacement is the treatment of choice for symptomatic severe aortic stenosis. Transcatheter technique is a viable alternative with promising results for inoperable patients.
Walter J. Gomes +7 more
doaj +2 more sources
Looking Back to Look Forward: What to Expect in a Redo Surgery for a Bioprosthesis Replacement
Redo surgeries are becoming more common because of an increased rate of bioprosthesis implantation. We performed a retrospective study on patients who underwent redo replacement of an aortic and/or mitral bioprosthesis between 2005 and 2018 to evaluate ...
Ilaria Giambuzzi +2 more
exaly +2 more sources
Online monitoring of myocardial bioprosthesis for cardiac repair
Background/objectives The aim of this study was to develop a myocardial bioprosthesis for cardiac repair with an integrated online monitoring system. Myocardial infarction (MI) causes irreversible myocyte loss and scar formation.
Cristina Prat-Vidal +2 more
exaly +3 more sources
VITTA TRIAL – safety and performance at 3-year follow-up after implantation of the VIVERE® aortic bioprosthesis [PDF]
IntroductionThe durability of aortic bioprostheses remains limited by progressive tissue calcification, the main mechanism underlying structural valve deterioration.
Luiz Carlos Bettiati Junior +3 more
doaj +2 more sources
Porcine or Bovine Tissue Valves: Which are Better for Surgical Aortic Valve Replacement? [PDF]
The choice between mechanical and bioprosthetic aortic valve implants is affected by relatively clear criteria. However, the choice between porcine or pericardial valve is more complex regarding bioprosthetic devices.
Georgi Manchev +4 more
doaj +3 more sources
Matryoshka procedure for Valve‐in‐Valve TAVI failure
Valve‐in‐valve transcatheter valve implantation (ViV‐TAVI) procedures for deteriorated bioprosthesis are an established therapeutic option for high‐risk patients. The presence of the fixed sewing ring of the bioprosthesis can hamper appropriate expansion
Vittoria Lodo +7 more
doaj +1 more source
The importance of the use of bovine pericardium for surgical reconstructions: a systematic review
Introduction: The use of bovine pericardium started in 1972 in cardiovascular surgeries. From the evolution of tissue engineering with care in the preparation of the material, minimizing the risk of rejection and facilitating the use for various types
Gomes, Maria Clara Nonato Soares +2 more
doaj +1 more source

